Nazanin Hajarol Asvadi MD, Presenter: Nothing to Disclose

Priyanush Kandakatla MD, Abstract Co-Author: Nothing to Disclose

Colin J. McCarthy MD, Abstract Co-Author: Nothing to Disclose

Arash Anvari MD, Abstract Co-Author: Nothing to Disclose

Raul Nirmal Uppot MD, Abstract Co-Author: Nothing to Disclose

Ronald Steven Arellano MD, Abstract Co-Author: Nothing to Disclose

  1. To discuss the selection criteria utilized by several national organization for patients awaiting liver transplantation. 2. To describe the multifaceted role interventional radiology (IR) in the management of patients with end-stage liver disease awaiting liver transplantation.

1. Review of incidence of end-stage liver disease worldwide and liver transplantation as a definite therapy for these patients. 2. Review of Milan criteria and survival rate in HCC patients. 3. Describe United Network for Organ Sharing (UNOS) and its transplant allocation policies regarding waiting period in different regions and drop off rate while awaiting liver transplantation. 4. Discuss the role of interventional radiology (biopsy, thermal ablation, embolization, imaging) in the management of patients awaiting liver transplantation.

http://abstract.rsna.org/uploads/2014/14005627/14005627_ja5g.pdf

Asvadi, N, Kandakatla, P, McCarthy, C, Anvari, A, Uppot, R, Arellano, R, Bridging the Gap: The Role of Interventional Radiology in the Management of Patients with End-Stage Liver Disease Awaiting Liver Transplantation.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14005627.html